IMPACT OF BUSULFAN, ETOPOSIDE AND HIGH-DOSE ARA-C (BEA) CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN AML

被引：0

作者：

Sanz, Jaime ^{[1
,2
]}

Labopin, Myriam ^{[3
]}

Daskalakis, Michael ^{[4
]}

Broers, A. E. C. ^{[5
]}

Van Gorkom, Gwendolyn ^{[6
]}

Meijer, Ellen ^{[7
]}

Gedde-Dah, Tobias ^{[8
]}

Montoro, Juan ^{[1
,2
]}

Arcese, William ^{[9
]}

Antonio Perez-Simon, Jose ^{[10
]}

Schaap, N. ^{[11
]}

Maertens, Johan ^{[12
]}

Vrhovac, Radovan ^{[13
]}

Lanza, Francesco ^{[14
]}

Gorin, Norbert Claude ^{[15
]}

Mohty, Mohamad ^{[15
]}

Ciceri, Fabio ^{[16
]}

机构：

[1] Hosp Univ & Politecn La Fe, Valencia, Spain

[2] Inst Carlos III, CIBERONC, Madrid, Spain

[3] Hosp St Antoine, EBMT Paris Off, Paris, France

[4] Univ Hosp Bern, Paediat Hematol Oncol, Bern, Switzerland

[5] Erasmus MC, Univ Med Ctr Rotterdam, Inst Canc, Rotterdam, Netherlands

[6] Univ Hosp Maastricht, Maastricht, Netherlands

[7] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[8] Oslo Univ Hosp, Sect Stem Cell Transplantat, Clin Canc Med, Rikshosp, Oslo, Norway

[9] Tor Vergata Univ Rome, Stem Cell Transplant Unit, Policlin Univ Vergata, Rome, Italy

[10] Hosp Univ Virgen Rocio, Serv Hematol & Hemoterapia, Serv Andaluz Salud, Seville, Spain

[11] Nijmegen Med Ctr, Nijmegen, Netherlands

[12] Univ Hosp Gasthuisberg, Leuven, Belgium

[13] Univ Hosp Ctr Rebro, Zagreb, Croatia

[14] Osped Civile, Unita Operat Ematol, Ravenna, Italy

[15] Sorbonne Univ, Hop St Antoine, INSERM UMRs 938, Paris, France

[16] Ospedale San Raffaele srl, Haematol & BMT, Milan, Italy

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O054

引用

页码：57 / 57

页数：1

共 50 条

[41] LEAM protocol (Lomustine, Etoposide, Ara-C/Cytarabine, Melphalan) as high-dose chemotherapy (HDT) before autologous stem cell transplant (ASCT) for lymphoid malignancies: a monocentric experience
Fornecker, L. M.
Ledoux, M. P.
Toussaint, E.
Laplace, A.
El Aatmani, A.
Fohrer-Sonntag, C.
Bilger, K.
Lioure, B.
BONE MARROW TRANSPLANTATION, 2016, 51 : S238 - S239
[42] Long-term follow up on patients with Hodgkin lymphoma treated with high-dose BCNU, etoposide, Ara-C, cyclophosphamide and autologous hemopoietic stem cell rescue.
Gingrich, RD
Hayashi, M
Silverman, MM
Lee, CK
Hohl, RJ
Schlueter, A
BLOOD, 2001, 98 (11) : 392B - 392B
[43] TREATMENT OF INTRAOCULAR LYMPHOMA WITH HIGH-DOSE ARA-C
BAUMANN, MA
RITCH, PS
HANDE, KR
WILLIAMS, GA
TOPPING, TM
ANDERSON, T
CANCER, 1986, 57 (07) : 1273 - 1275
[44] Continuous High-Dose Idarubicin and Busulfan As Conditioning Regimen for Chinese Patients with Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation
Ming, Hong
Qian, Sixuan
Peng, Liu
Wu Hanxin
Qiu Hongxia
Hua, Lu
Zhang Sujiang
Wei, Xu
BLOOD, 2012, 120 (21)
[45] Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
Byun, Ja Min
Lee, Jayoun
Shin, Sang-Jin
Kang, Minjoo
Yoon, Sung-Soo
Koh, Youngil
BLOOD RESEARCH, 2018, 53 (02) : 105 - 109
[46] LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal toxicity.
Orchard, K
Giles, C
Apperley, J
Goldman, JM
Kanfer, EJ
Samson, D
BLOOD, 1997, 90 (10) : 1855 - 1855
[47] RELATIONSHIP OF [H-3] ARA-C INCORPORATION AND RESPONSE TO THERAPY WITH HIGH-DOSE ARA-C IN AML PATIENTS - A LEUKEMIA INTERGROUP STUDY
RAZA, A
GEZER, S
ANDERSON, J
LYKINS, J
BENNETT, J
BROWMAN, G
GOLDBERG, J
LARSON, R
VOGLER, R
PREISLER, HD
EXPERIMENTAL HEMATOLOGY, 1992, 20 (10) : 1194 - 1200
[48] BIOCHEMICAL AND PHARMACOLOGICAL BASIS OF HIGH-DOSE ARA-C
SEEBER, S
ONKOLOGIE, 1985, 8 (01): : 4 - 7
[49] TOXICITY OF HIGH-DOSE ARA-C IN CHILDREN AND ADOLESCENTS
BARRIOS, NJ
TEBBI, CK
FREEMAN, AI
BRECHER, ML
CANCER, 1987, 60 (02) : 165 - 169
[50] THE ASSOCIATION OF HIGH-DOSE ARA-C AND DEMYELINATING POLYNEUROPATHY
OPENSHAW, H
SLATKIN, NE
HINTON, DR
ZAIAS, B
STEIN, AS
ANNALS OF NEUROLOGY, 1995, 38 (02) : 342 - 342

← 1 2 3 4 5 →